CA2070492A1 - Acetohydroxamic acid compound, pharmaceutical compositions containing this compound and processes for the preparation of this compound and these compositions - Google Patents
Acetohydroxamic acid compound, pharmaceutical compositions containing this compound and processes for the preparation of this compound and these compositionsInfo
- Publication number
- CA2070492A1 CA2070492A1 CA002070492A CA2070492A CA2070492A1 CA 2070492 A1 CA2070492 A1 CA 2070492A1 CA 002070492 A CA002070492 A CA 002070492A CA 2070492 A CA2070492 A CA 2070492A CA 2070492 A1 CA2070492 A1 CA 2070492A1
- Authority
- CA
- Canada
- Prior art keywords
- cyclodextrin
- thien
- compound
- methyl
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEP4123613.0 | 1991-07-17 | ||
| DE4123613A DE4123613C1 (cg-RX-API-DMAC7.html) | 1991-07-17 | 1991-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2070492A1 true CA2070492A1 (en) | 1993-01-18 |
Family
ID=6436313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002070492A Abandoned CA2070492A1 (en) | 1991-07-17 | 1992-06-04 | Acetohydroxamic acid compound, pharmaceutical compositions containing this compound and processes for the preparation of this compound and these compositions |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5252562A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0523499B1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE120460T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU644533B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2070492A1 (cg-RX-API-DMAC7.html) |
| DE (2) | DE4123613C1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0523499T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2073214T3 (cg-RX-API-DMAC7.html) |
| GR (1) | GR3015673T3 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1005189A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070111965A1 (en) * | 2005-11-15 | 2007-05-17 | Kipp James E | Compositions comprising lipoxygenase inhibitors and cyclodextrin |
| CN107233337A (zh) | 2009-04-29 | 2017-10-10 | 阿马里纳药物爱尔兰有限公司 | 含有epa和心血管剂的药物组合物以及使用其的方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2559699B2 (ja) * | 1985-03-16 | 1996-12-04 | ザ ウエルカム フアウンデ−シヨン リミテツド | 新規なアリ−ル誘導体 |
| GB8531839D0 (en) * | 1985-12-30 | 1986-02-05 | Wellcome Found | Aryl derivatives |
| IE59397B1 (en) * | 1985-03-16 | 1994-02-23 | Wellcome Found | New aryl derivatives |
| GB8531838D0 (en) * | 1985-12-30 | 1986-02-05 | Wellcome Found | Aryl derivatives |
| US5036157A (en) * | 1986-03-11 | 1991-07-30 | Burroughs Wellcome Co. | Aryl derivatives |
| US5026729A (en) * | 1987-02-10 | 1991-06-25 | Abbott Laboratories | Lipoxygenase inhibiting compounds |
| CA1316935C (en) * | 1987-12-09 | 1993-04-27 | Hiromitsu Saito | Hydroxamic acid derivatives |
| EP0351214A1 (en) * | 1988-07-14 | 1990-01-17 | The Wellcome Foundation Limited | Anti-inflammatory aryl derivatives |
| EP0412939A3 (en) * | 1989-08-11 | 1991-09-04 | Ciba-Geigy Ag | Certain benzopyran and benzothiopyran derivatives |
| FR2660309B1 (fr) * | 1990-03-27 | 1992-07-17 | Roussel Uclaf | Nouveaux complexes de l'acide tiaprofenique ou de ses esters insolubles ou partiellement solubles avec les cyclodextrines ou leurs derives. |
-
1991
- 1991-07-17 DE DE4123613A patent/DE4123613C1/de not_active Expired - Fee Related
-
1992
- 1992-06-04 CA CA002070492A patent/CA2070492A1/en not_active Abandoned
- 1992-07-06 EP EP92111427A patent/EP0523499B1/de not_active Expired - Lifetime
- 1992-07-06 DE DE59201764T patent/DE59201764D1/de not_active Expired - Lifetime
- 1992-07-06 ES ES92111427T patent/ES2073214T3/es not_active Expired - Lifetime
- 1992-07-06 DK DK92111427.8T patent/DK0523499T3/da active
- 1992-07-06 AT AT92111427T patent/ATE120460T1/de not_active IP Right Cessation
- 1992-07-10 US US07/911,623 patent/US5252562A/en not_active Expired - Lifetime
- 1992-07-16 AU AU20360/92A patent/AU644533B2/en not_active Ceased
-
1995
- 1995-04-03 GR GR950400817T patent/GR3015673T3/el unknown
-
1998
- 1998-05-19 HK HK98104298A patent/HK1005189A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0523499B1 (de) | 1995-03-29 |
| GR3015673T3 (en) | 1995-07-31 |
| EP0523499A1 (de) | 1993-01-20 |
| US5252562A (en) | 1993-10-12 |
| ATE120460T1 (de) | 1995-04-15 |
| ES2073214T3 (es) | 1995-08-01 |
| DK0523499T3 (da) | 1995-06-12 |
| DE4123613C1 (cg-RX-API-DMAC7.html) | 1993-02-04 |
| AU2036092A (en) | 1993-01-28 |
| DE59201764D1 (de) | 1995-05-04 |
| AU644533B2 (en) | 1993-12-09 |
| HK1005189A1 (en) | 1998-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0196184A2 (en) | Aryl derivatives | |
| US4816487A (en) | 1-(2-hydroxyaryl)-alkane-1-on-oximes-procedure of preparation and use in pharmaceuticals | |
| JPS58135870A (ja) | チアゾ−ル誘導体、その製造法およびそれを有効成分とする医薬 | |
| EP0033255A1 (fr) | Nouvelles oximes dérivées de l'érythromycine A, leur préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant | |
| WO2001025192A1 (en) | Guanidine derivatives and their use in the production of a medicament for blocking xanthine oxidase/dehydrogenase | |
| CN116897153A (zh) | 一种三氮唑类衍生物及其制备方法和应用 | |
| CA2123267A1 (fr) | Indoles substitues leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| EP0305947B1 (en) | Hydantoin derivatives, process for their preparation and pharmaceutical compositions containing the same as well as their use | |
| JP2001504436A (ja) | ロイコトリエン生合成の阻害物質である対称性ビス−ヘテロアリールメトキシフェニルアルキルカルボキシレート | |
| US5441932A (en) | Sugar compounds for inhibition of the biosynthesis of sugar chains containing sialic acid | |
| JPS63253070A (ja) | イミダゾール誘導体 | |
| US5252562A (en) | Acetohydroxamic compound and complexes pharmaceutical compositions containing them and processes of preparation and use | |
| US5356921A (en) | Imidazolylphenol compounds, pharmaceutical compositions containing them, and processes for preparing such compounds and compositions | |
| CA1119616A (en) | Hydroxamic acid compounds, method for preparation thereof and medicaments containing such compounds | |
| AP339A (en) | Indenoindoles compounds. | |
| US7863323B1 (en) | Flavonols | |
| EP4129983B1 (en) | Crystal form of nitroxoline prodrug, pharmaceutical composition containing same, and preparation method therefor and application thereof | |
| JPH0514708B2 (cg-RX-API-DMAC7.html) | ||
| EP0237138A1 (en) | Heterocyclic compounds, their preparation and, pharmaceutical compositions containing them | |
| US6004966A (en) | Use of xanthine oxidase inhibitors as anti-ischaemic agents | |
| EP0320000A2 (en) | Hydroxamic acid derivatives | |
| EP0461237B1 (fr) | Utilisation de derives du 9,10-dihidrophenanthrene pour la preparation d'un medicament anti-tumoral et nouveaux derives | |
| US4713390A (en) | Sulfurated hydantoin derivatives and pharmaceutical compositions containing same | |
| EP0298134A1 (en) | Aromatic heterocyclic carboxylic acid amide derivatives, process for their preparation, and pharmaceutical composition containing same | |
| US5475028A (en) | 2-aminoethanesulfonic acid zinc complex |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |